Raltegravir
ISRCTN43622374
Phase 3 small_molecule completed
Quick answer
Raltegravir for Human Immunodeficiency Virus is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Human Immunodeficiency Virus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed